Restanex® - Mometasone 0.05%
Restanex® is a nasal suspension. Each 100mL contains 0.05g Mometasone furoate with Benzalkonium Chloride as preservative. Each puff contains 50 mcg Mometasone furoate.
Nasal corticosteroid inhibits the migration of inflammatory cells in to the nasal tissue (the late-phase or late-onset allergic reaction) which may play a significant role in the pathology of chronic rhinitis.
Restanex® nasal sprays are indicated in the treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, nasal allergic disorders, noninfections inflammatory conditions and polyps.
Dosage and Administration:
-In prophylaxis and treatment of allergic rhinitis:
Adult and adolescent dose: 100 mcg (2 sprays) in each nostril once a day (total daily dose, 200 mcg); then being decreased to a maintenance dose of 50 mcg (1 spray) in each nostril once a day, according to patient response.
Children 2 to 11 years of age: 50 mcg (1 spray) in each nostril once daily.
-In Nasal polyps (18 years of age and older):
2 sprays in each nostril twice daily (total daily dose 400 mcg).
Sina Darou Restanex® Nasal Sprays are available as Mometasone furoate 0.05% suspension in 20 mL plastic bottles with pump sprays and protective caps.